Today hyperfractionated radiotherapy in combination with cisplatin and 5-FU is the most effective treatment modality of patients with nasopharyngeal carcinoma. However late complications of this method are investigated poorly what was the aim of this research. Analyzing treatment results of 118 patients who achieved complete tumor regression we revealed that radiation damages more often and severe at patients who received more aggressive treatment - accelerated hyperfractionated radiotherapy with and without concurrent cytotoxic drugs. But application of complex prophylaxis and treatment measures by radiation oncologists in cooperation with other specialist (stomatologists, dermatologists, endocrinologists etc.) allow to control toxicity and finalize planned treatment schedule.

Download full-text PDF

Source

Publication Analysis

Top Keywords

patients nasopharyngeal
8
hyperfractionated radiotherapy
8
treatment
5
[postradiotherapy complications
4
complications correction
4
correction ways
4
patients
4
ways patients
4
nasopharyngeal carcinoma]
4
carcinoma] today
4

Similar Publications

Should We Transplant Candidates With a Positive SARS-CoV-2 RT-PCR Test?

Transplantation

January 2025

Department of Hepatogastroenterology, Edouard Herriot University Hospital, University Lyon-1, Lyon, France.

Background: It remains unclear whether physicians should accept transplantation offers for candidates with a positive SARS-CoV-2 reverse transcription polymerase chain reaction test due to the potential risk of severe infection after initiating immunosuppressive therapy.

Methods: A multicenter observational study was conducted in 19 French solid organ transplantation units. Patients on the waiting list for liver or kidney transplants who had a positive SARS-CoV-2 reverse transcription polymerase chain reaction nasopharyngeal swab at the time of transplantation were recorded.

View Article and Find Full Text PDF

Unlabelled: Respiratory tract infections are major global health issues that require rapid and accurate diagnostic methods. Multiplex quantitative PCR (qPCR) is commonly used for pathogen detection in respiratory samples. However, the optimal specimen selection for detecting bacterial pathogens is not well-explored.

View Article and Find Full Text PDF

Background: Central venous access devices (CVAD) are widely used in patient care, providing an essential, reliable pathway for patients to receive chemotherapy, long-term infusions, and nutritional support. However, a system of exercise management has not been developed in patients with CVAD.

Purpose: To evaluate and summarize the evidence for management exercise in patients with CVAD and provide guidance for clinical practice.

View Article and Find Full Text PDF

Low albumin-to-creatinine ratios (ACR) are associated with poor outcomes in cancer patients.

BMC Cancer

January 2025

Department of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.

Background: The albumin-to-creatinine ratio (ACR) is known to predict prognosis in liposarcoma patients, but its role in other tumors remains unclear. This study aimed to evaluate the prognostic relationship between ACR and common solid tumors.

Methods: Data from the Investigation on Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) between 2013 and 2022 were used to analyze patients under 65 years old with solid tumors.

View Article and Find Full Text PDF

Purpose: Bodyweight loss is commonly found in Nasopharyngeal Carcinoma patients during Concurrent Chemo-radiotherapy (CCRT) and has implications for treatment decisions. However, the prognostic value of this weight loss remains uncertain. We addressed it by proposing a novel index Weight Censorial Score (WCS) that characterizes the patient-specific CCRT response on actual to estimated weight loss.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!